Navigation Links
Device Can "Battle" Hospital Infections

An innovative University at Buffalo air sterilization technology that the U.S. Department of Defense is funding to protect troops on the battlefield //soon may be protecting hospital patients from deadly infections, thanks to recent funding from the New York State Office of Science, Technology and Academic Research (NYSTAR).

The funding comes as hospital-acquired infections, many of which are becoming increasingly difficult to treat, are on the rise.

The $674,900 grant from NYSTAR's Technology Transfer Investment Program will allow Buffalo BioBlower Technologies, the UB spin-off company that licensed the technology from UB, to develop a health-care prototype and take it into clinical trials.

"Receiving this NYSTAR grant is a major boost that will help ensure the success of Buffalo BioBlower," said Robert Genco, D.D.S., Ph.D., vice provost and director of the UB Office of Science, Technology Transfer and Economic Outreach (STOR). "We are very confident that in the next few years, companies like Buffalo BioBlower and others spun out of the university will make major contributions to economic development in Western New York."

The NYSTAR funding will support construction of a test room for evaluating a prototype for health-care applications.

The goal of the award is the development of a health-care division for Buffalo BioBlower Technologies, potentially creating up to 100 new jobs.

In tests funded by the Department of Defense and conducted last fall, the UB team has shown it can eradicate greater than 99.9999 percent of the spores of an anthrax surrogate in an airstream, according to the researchers.

"That's better than any conventional technology on the market." said James F. Garvey, Ph.D., UB professor of chemistry in the College of Arts and Sciences and co-founder and chief technical officer of Buffalo BioBlower Technologies with John Lordi, Ph.D., chief executive officer. Lordi is a research professor in the Department of Mechanical and Aerospace Engineering in the UB School of Engineering and Applied Sciences.

"We input one million live, active spores of a thermally resistant bacterium into the BioBlower and only one live spore comes out," said Garvey.

Through compressive heating and pressure oscillations that break up and kill pathogens, the dual-use technology called BioBlower can be expected to rapidly and continuously eradicate even the smallest of airborne biological pathogens, such as bacteria, spores, viruses, influenza including bird flu, pollen and mold.

That contrasts with the current conventional technology, HEPA (High-Efficiency Particulate Air) paper filters, which trap large airborne spores and need to be changed frequently, stored carefully and subsequently destroyed.

"With HEPA filters, the spores are still alive, once they're collected, waiting to infect somebody," Garvey said. "We kill them at the source."

The issue could not be more critical to the health-care market.

"The Centers for Disease Control says going to the hospital is the fourth biggest killer in this country," Garvey noted, because of the high incidence of hospital-acquired infections, a problem that he said is contributing rapidly to spiraling health-care costs.

In addition, the device could be made compact enough to turn an ordinary hospital room into an instant isolation unit, Garvey said, or as large as necessary to install in a building's HVAC unit to provide purified air throughout an entire facility.

Buffalo BioBlower's administrative office is in UB's New York State Center of Excellence in Bioinformatics and Life Sciences.

Lordi says that's a clear advantage, especially in light of the recent NYSTAR funding.

"We will benefit from interactions with the researchers in the Center of Excellence, as well as with all of the people in hea lth care on the Buffalo Niagara Medical Campus as we learn more about the whole problem of infection control," Lordi said.

(Source: Newswise)
'"/>




Related medicine news :

1. Injection supports Heart Devices
2. New Heart-Screening Device ,An Accurate Predictor Of Heart Disease
3. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
4. Withdrawal Notice Issued For Older Pacemakers Due To Malfunctioning of the Device
5. New Implantable Device That Can Keep The Heart Ticking
6. Making MRIs Safe for Patients With Implantable Heart Devices
7. Researchers Develop Device For Detecting Atherosclerotic Plaques
8. A Cheap Device to Stop Snoring from New Zealand
9. Scientists Concerned Over Increasing Malfunction Of Heart Devices
10. Device For Improving Bone Mass In Osteoporosis
11. Anti-Microbial Coating For Use Over Biomedical Devices Developed
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... ... August 16, 2017 , ... A global leader in the treatment ... clinics in all 29 Indian states—bringing the country one step closer to eliminating clubfoot ... the nonprofit organization is on track to enroll 10,000 children in the clubfoot treatment ...
(Date:8/16/2017)... Atlanta, Georgia (PRWEB) , ... August 16, 2017 , ... ... to distribute premium original programming over four countries and millions of viewers in a ... available to rent or buy On-Demand and fully available on Blu Ray disc in ...
(Date:8/16/2017)... ... August 16, 2017 , ... TopConsumerReviews.com recently gave a best-in-class 5 ... , The healthcare industry in the United States has undergone major changes over the ... needing to have a doctor’s order to get a blood test or other lab ...
(Date:8/16/2017)... , ... August 16, 2017 , ... First Choice ... States, named Dr. Douglas J. Harrison, as the new Medical Director of its Sienna ... new facility Medical Director of our Sienna Plantation location,” said Dr. Michael (Derek) Caraway, ...
(Date:8/16/2017)... ... August 16, 2017 , ... With low back pain afflicting 8 of 10 Americans at some ... cousin – upper back pain. But this equally vexing condition stems from a variety of ... Kaixuan Liu, MD, PhD , founder and president of Atlantic Spine Center. , Nestled ...
Breaking Medicine News(10 mins):
(Date:7/31/2017)...  Diplomat Pharmacy, Inc. (NYSE: DPLO), has been named one ... by Crain,s Detroit Business . The annual ... three-year revenue growth. This year,s edition measures growth from 2013 ... the complete list, visit crainsdetroit.com/awards/fast_50/2017 .  ... said Phil Hagerman , CEO and chairman of Diplomat. ...
(Date:7/27/2017)... Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results ... reported second quarter net sales of $1.954 billion, an ... an increase of 2.1% on a constant currency basis.  ... LDR Holding Corporation acquisition, second quarter 2017 revenues decreased ... on a constant currency basis. ...
(Date:7/26/2017)... The Galien Foundation announced today the 2017 11 ... Award Nominees. Counted among the global health innovation industry,s most ... technology product achievement that improves the human condition. ... be U.S. Food and Drug Administration (FDA) approved for market ... impact human health. Sales data are not considered by the ...
Breaking Medicine Technology: